Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case report

Australas J Dermatol. 2021 Aug;62(3):e442-e443. doi: 10.1111/ajd.13568. Epub 2021 Feb 26.

Authors

Antonio Richetta¹, Federica Marraffa¹, Sara Grassi¹, Emilia Aquila¹, Agnieszka Dybala¹, Francesca Aprile², Manuela Merli²

Affiliations

¹ Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
² Department of Precision and Translational Medicine, Centre for the Diagnosis and Treatment of Portal Hypertension, Sapienza University of Rome, Rome, Italy.

PMID: 33634474
DOI: 10.1111/ajd.13568

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Dermatologic Agents / therapeutic use*
Humans
Male
Middle Aged
Psoriasis / drug therapy*
Severity of Illness Index
Treatment Outcome
Ustekinumab / therapeutic use*

Substances

Dermatologic Agents
Ustekinumab